A patient is receiving a dose of edrophonium. The nurse recognizes that this drug is given to determine the diagnosis of which disease?
Parkinson's disease
Alzheimer's disease
Myasthenia Gravis
Serotonin Syndrome
The Correct Answer is C
A. Parkinson's disease
Edrophonium is not used for the diagnosis of Parkinson's disease. Parkinson's disease is a neurodegenerative disorder characterized by motor symptoms such as tremors, rigidity, and bradykinesia. The diagnosis is typically based on clinical symptoms and neurological examination.
B. Alzheimer's disease
Edrophonium is not used for the diagnosis of Alzheimer's disease. Alzheimer's disease is a progressive neurodegenerative disorder affecting cognition. The diagnosis involves clinical evaluation, cognitive assessments, and sometimes imaging studies, but not the use of edrophonium.
C. Myasthenia Gravis
This is the correct choice. Edrophonium is used as a diagnostic tool in Myasthenia Gravis. In individuals with Myasthenia Gravis, the administration of edrophonium can lead to a temporary improvement in muscle strength, helping to confirm the diagnosis.
D. Serotonin Syndrome
Edrophonium is not used for the diagnosis of serotonin syndrome. Serotonin syndrome is a condition caused by an excess of serotonin, often due to the use of certain medications. Diagnosis is based on clinical symptoms and a history of serotonin-affecting medications, not the administration of edrophonium.
Nursing Test Bank
Naxlex Comprehensive Predictor Exams
Related Questions
Correct Answer is A
Explanation
A. Carbidopa-levodopa
The symptoms described, including a shuffling gait, lack of facial expression, and tremors at rest, are characteristic of Parkinson's disease. Carbidopa-levodopa is a common medication used in the management of Parkinson's disease.
B. Donepezil
Donepezil is used in the treatment of Alzheimer's disease, a condition characterized by cognitive decline and memory impairment. It is not indicated for Parkinson's disease.
C. Rivastigmine
Rivastigmine is another medication used in the treatment of Alzheimer's disease, and it is also used in Parkinson's disease dementia. However, it is not the primary medication for the motor symptoms of Parkinson's disease.
D. Tacrine
Tacrine was once used in the treatment of Alzheimer's disease, but it is no longer commonly prescribed due to safety concerns and the availability of newer, safer medications. It is not indicated for Parkinson's disease.
Correct Answer is D
Explanation
A. Bradycardia
Bradycardia is not a common side effect of diphenoxylate with atropine. Atropine, which is included in the combination, has anticholinergic effects that can lead to an increased heart rate (tachycardia), not bradycardia.
B. Fluid retention
Fluid retention is not a common side effect of diphenoxylate with atropine. In fact, the medication is used to treat severe diarrhea, and the goal is to decrease fluid loss associated with diarrhea rather than causing fluid retention.
C. Nervousness and tremors
Nervousness and tremors are not common side effects of diphenoxylate with atropine. Atropine's anticholinergic effects may cause nervousness, but these effects are generally not prominent at therapeutic doses.
D. Respiratory depression
This is the correct choice. Respiratory depression is a potential side effect of diphenoxylate with atropine, particularly if the medication is misused or taken in excessive amounts. Atropine is included in the combination to discourage misuse, as it can cause unpleasant anticholinergic effects.
Whether you are a student looking to ace your exams or a practicing nurse seeking to enhance your expertise , our nursing education contents will empower you with the confidence and competence to make a difference in the lives of patients and become a respected leader in the healthcare field.
Visit Naxlex, invest in your future and unlock endless possibilities with our unparalleled nursing education contents today